Evaluation of the effectiveness of platelet-rich plasma in the treatment of Asherman's syndrome

Comparison of the effectiveness of hormone therapy alone with hormone therapy and platelet-rich plasma in the improvement of Asherman's syndrome after hysteroscopy in educational centers of Isfahan University of Medical Sciences

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200316046789N1

Enrollment

Registered

2022-02-11

Start date

2020-03-20

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asherman syndrome. Intrauterine synechiae

Interventions

Intervention 1: Intervention group:case (PRP and hormone therapy group) (n = 30/each groups). The selection of patients in two groups was completely random. 8.5 ml of peripheral venous blood of patie

Eligibility

Sex/Gender

Female

Age

18 Years to 43 Years

Inclusion criteria

Inclusion criteria: Clinical diagnosis of Asherman's syndrome Age: 18 to 43 years old Informed consent to participate in the study

Exclusion criteria

Exclusion criteria: Simultaneous infection of the uterus and vagina Hemoglobin less than 11 Platelet less than 150,000 History of anticoagulant use Dissatisfaction with entering the study

Design outcomes

Primary

Measure	Time frame
Uterine adhesion grade. Timepoint: 6 to 8 weeks later hysteroscopy. Method of measurement: Histroscopy.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Derakhshandeh

Esfahan University of Medical Sciences

Zderakhshandeh2020@gmail.com+98 31 3792 3370

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026